or Try an Advanced Search...

    Technical Analysis for ATAI - ATAI Life Sciences N.V.

    Grade Last Price % Change Price Change
    B 1.59 -8.09% -0.14
    ATAI closed down 8.09 percent on Wednesday, November 20, 2024, on 1.9 times normal volume. It was able to bounce off of its 200 day moving average, an important long-term support line.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Up Up
    Historical ATAI trend table...
    Date Alert Name Type % Chg
    200 DMA Support Bullish 0.00%
    Upper Bollinger Band Walk Strength 0.00%
    Inside Day Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Upper Bollinger Band Touch Strength 0.00%
    200 DMA Support Bullish -8.09%
    Calm After Storm Range Contraction -8.09%
    Upper Bollinger Band Walk Strength -8.09%
    Wide Bands Range Expansion -8.09%
    Above Upper BB Strength -8.09%
    Older End-of-Day Signals for ATAI ...

       Recent Intraday Alerts

    Alert Time
    200 DMA Support about 16 hours ago
    Fell Below 200 DMA about 17 hours ago
    Down 10% about 17 hours ago
    Down 1 ATR about 17 hours ago
    Possible Inside Day about 17 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    ATAI Chart by TradingView
    Basic chart:

    Profile

    atai is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai was founded in 2018 as a response to the significant unmet need and lack of innovation in the mental health treatment landscape, as well as the emergence of therapies that previously may have been overlooked or underused, including psychedelic compounds and digital therapeutics. atai is headquartered in Berlin, with offices in New York and London.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Medication Disability Mental Health Psychiatry Mental Disorder Positive Psychology Mental Health Disorders

    Is ATAI a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 19 Oxbridge Re Holdings Among 3 US Penny Stocks To Watch
    Nov 15 RFK and the 'MAHA Trade': Vaccine makers down, psychedelic shares up
    Nov 13 Atai Q3 Report: Strong Cash Position, Clinical Pipeline Growth
    Nov 13 ATAI Life Sciences GAAP EPS of -$0.16 in-line
    Nov 13 atai Life Sciences Reports Third Quarter 2024 Financial Results and Provides Corporate Updates
    Nov 11 Altimmune Appoints Life Sciences Industry Veteran Greg Weaver as Chief Financial Officer
    Nov 6 Massachusetts psychedelics legalization initiative poised to fail
    Oct 21 374Water And 2 Other Promising US Penny Stocks To Watch
    Oct 15 atai Life Sciences to Participate in the 2024 Maxim Healthcare Virtual Summit
    Sep 13 MDMA Therapy For PTSD Faces FDA Delay: Are There Other Ways Forward?
    See more ATAI news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 2.85
    52 Week Low 1.025
    Average Volume 1,232,166
    200-Day Moving Average 1.56
    50-Day Moving Average 1.24
    20-Day Moving Average 1.32
    10-Day Moving Average 1.51
    Average True Range 0.18
    RSI (14) 61.54
    ADX 34.03
    +DI 33.11
    -DI 8.26
    Chandelier Exit (Long, 3 ATRs) 1.41
    Chandelier Exit (Short, 3 ATRs) 1.58
    Upper Bollinger Bands 1.75
    Lower Bollinger Band 0.88
    Percent B (%b) 0.81
    BandWidth 66.30
    MACD Line 0.12
    MACD Signal Line 0.08
    MACD Histogram 0.0434
    Fundamentals Value
    Market Cap 263.96 Million
    Num Shares 166 Million
    EPS -0.43
    Price-to-Earnings (P/E) Ratio -3.70
    Price-to-Sales 859.87
    Price-to-Book 1.09
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.96
    Resistance 3 (R3) 1.99 1.89 1.90
    Resistance 2 (R2) 1.89 1.79 1.88 1.88
    Resistance 1 (R1) 1.74 1.73 1.69 1.71 1.86
    Pivot Point 1.64 1.64 1.61 1.63 1.64
    Support 1 (S1) 1.49 1.54 1.44 1.47 1.32
    Support 2 (S2) 1.39 1.49 1.38 1.30
    Support 3 (S3) 1.24 1.39 1.28
    Support 4 (S4) 1.22